Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma.
Saved in:
| Title: | Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma. |
|---|---|
| Authors: | van der Horst HJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Gelderloos AT; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Chamuleau MED; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Breij ECW; Genmab, Utrecht, The Netherlands., Zweegman S; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Nijhof IS; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Overdijk MB; Genmab, Utrecht, The Netherlands., Mutis T; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and. |
| Source: | Blood advances [Blood Adv] 2021 Apr 27; Vol. 5 (8), pp. 2165-2172. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33885752 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22van+der+Horst+HJ%22">van der Horst HJ</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and.<br /><searchLink fieldCode="AU" term="%22Gelderloos+AT%22">Gelderloos AT</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and.<br /><searchLink fieldCode="AU" term="%22Chamuleau+MED%22">Chamuleau MED</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and.<br /><searchLink fieldCode="AU" term="%22Breij+ECW%22">Breij ECW</searchLink>; Genmab, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Zweegman+S%22">Zweegman S</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and.<br /><searchLink fieldCode="AU" term="%22Nijhof+IS%22">Nijhof IS</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and.<br /><searchLink fieldCode="AU" term="%22Overdijk+MB%22">Overdijk MB</searchLink>; Genmab, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mutis+T%22">Mutis T</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2021 Apr 27; Vol. 5 (8), pp. 2165-2172. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33885752 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2020003731 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2165 Titles: – TitleFull: Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: van der Horst HJ – PersonEntity: Name: NameFull: Gelderloos AT – PersonEntity: Name: NameFull: Chamuleau MED – PersonEntity: Name: NameFull: Breij ECW – PersonEntity: Name: NameFull: Zweegman S – PersonEntity: Name: NameFull: Nijhof IS – PersonEntity: Name: NameFull: Overdijk MB – PersonEntity: Name: NameFull: Mutis T IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 04 Text: 2021 Apr 27 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 5 – Type: issue Value: 8 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |
